Abbott Laboratories settled an appeal regarding a $495 million verdict involving its specialized formula for premature infants.
A Missouri appeals court filing confirmed the settlement, though the specific terms remain confidential.
A St. Louis jury originally delivered the verdict in 2024.
The lawsuit alleged the formula caused necrotizing enterocolitis (NEC), a serious intestinal disease in premature newborns.
Abbott and other formula manufacturers currently face roughly 1,000 similar lawsuits related to NEC.